Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin

NCT01163851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Dyslipidemia

Interventions

BIOLOGICAL: 4 mg/kg
BIOLOGICAL: 0.5 mg/kg

Sponsor

Pfizer